Date of Award

Spring 6-10-2022

Document Type

Honors Project

University Scholars Director

Christine Chaney

First Advisor/Committee Member

Ben McFarland




FOXF2 is a transcription factor that plays a crucial role in organ development, and recent studies have shown that it suppresses tumor growth and progression in mouse prostate models by attenuating the cancer-associated fibroblasts (CAF) phenotype and transcriptionally downregulating Cxcl5. However, the effects of FOXF2 overexpression in prostate cancer cells have not been extensively studied. Here, we investigate the impact of FOXF2 overexpression in prostate cancer cells and demonstrate that it leads to a significant increase in cell apoptosis and a decrease in proliferation. These findings suggest that FOXF2 may have potential as an immunotherapy drug target for prostate cancer treatment.

Copyright Status

Additional Rights Information

Copyright held by author.

Copyright Status